Pharmafile Logo
Pharmafocus logo
Advanced Search

Portland Health hires director from Hanover

March 31, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, Portland Health, a bpi, comms

Comms agency Portland Health has appointed Matt Worrall as an associate director who joins the firm from Hanover Communications. Worrall …

Appointment
DOH image

Life sciences boost from government

March 31, 2014
Research and Development, Sales and Marketing DoH, NHS, UK, government, life sciences, medcity

The UK government is to launch an improved offering for the life sciences sector by combining the functions of the …

News
Stelara image

Stelara hit by final NICE rejection

March 28, 2014
Sales and Marketing Janssen, NICE, UK, arthritis, psoriatic, stelar

In final draft guidance released today NICE says it cannot recommend Janssen’s psoriatic arthritis drug Stelara. Specifically, the pricing watchdog …

News
obesity

UK health report flags weight and dementia risks

March 28, 2014
Sales and Marketing Dame Sally Davies, Public Health England, dementia, obesity

A new Department of Health report suggests that being overweight is now the norm in England – and that deafness …

News

Baxter to split in two next year

March 28, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro

Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …

News
Boris image

MedCity to launch in April

March 28, 2014
Medical Communications, Research and Development, Sales and Marketing Boris Johnson, London, UCL, Wellcome, medcity, medical city

The eagerly anticipated launch of ‘MedCity’ will be announced in April, Pharmafile has learned, as the UK government looks to …

News
screen_shot_2014-03-28_at_08

CAP-CMV appoints Albrecht Läufer as chief executive

March 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Albrecht Läufer, CAP-CMV, cevec

Biotech firm CAP-CMV which is a spin-out of CEVEC Pharmaceuticals has appointed industry veteran Dr Albrecht Läufer as its chief …

Appointment
AstraZeneca image

AstraZeneca opens up research

March 28, 2014
Medical Communications, Sales and Marketing AstraZeneca, data, research, transparency, website

AstraZeneca has created a new means of sharing some of its data with scientists, such as its bank of live …

News
GSK image

Europe grants Eperzan licence

March 27, 2014
Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly

The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …

News
Alli image

Alli bottles tampered with in US, drug recalled

March 27, 2014
Manufacturing and Production, Sales and Marketing Alli, FDA, GSK, Roche, Xenical, obesity, weight loss

GlaxoSmithKline has admitted that some bottles of its weight-loss drug Alli bought in the US have been tampered with. US …

News
GSK image

GSK and partners set up big data project

March 27, 2014
Medical Communications, Research and Development, Sales and Marketing Big Data, European Bioinformatics Institute, GSK, Wellcome Trust Sanger Institute, cttv

GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute have come together to launch an open access research …

News
NICE image

NICE launches VBA consultation

March 27, 2014
Sales and Marketing Dillon, England, NHS, NICE, VBP, catchpole, pars, vba

NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …

News
screen_shot_2014-03-27_at_07

Immunocore chief executive cements role at Adaptimmune

March 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble

Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …

Appointment
cruk_selfie

Social media cancer drive raises £8 million

March 26, 2014
Medical Communications, Sales and Marketing CRUK, Cancer, funding

News

Adaptimmune wins fund payout

March 26, 2014
Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme

Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …

News
NHS image

UK government launches ‘Sign up to Safety’ initiative

March 26, 2014
Sales and Marketing Francis, Hunt, Mid Staffs, NHS, safety, sign up

A new ambition to reduce avoidable harm in the NHS by half over the next three years, cut costs and …

News
Xalkori image

Pfizer’s Xalkori impresses in new setting

March 26, 2014
Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer

Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …

News
ernesto_quinteros

J&J appoints chief design officer

March 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ernesto Quinteros, J&J, JJ, belkin, design

Johnson & Johnson has reached outside of its industry and into the design and technology realm with its latest appointment.  …

Appointment
Novartis image

FDA unconvinced on Novartis heart drug

March 26, 2014
Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin

The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …

News
Janssen image

Janssen psoriasis drug beats placebo

March 25, 2014
Research and Development, Sales and Marketing Janssen, dermatology, guselkumab

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026